FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileNutriband Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NTRBW
Nutriband Inc. Stock AnalysisComprehensive stock analysis for Nutriband Inc. (NTRBW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisNTRBW
NTRBW
Nutriband Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NTRBW
  1. Home
  2. Stocks
  3. Nutriband Inc.

Nutriband Inc.

🇺🇸NTRBW•NASDAQ

Nutriband Inc.

🇺🇸NTRBW•NASDAQ
Market cap
$76.82M
Sentiment

Your view on NTRBW

Mkt Cap
$76.82M
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Nutriband Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Gareth Sheridan
Headquarters
121 South Orange Avenue, Orlando, FL, US
Industry
Biotechnology
Sector
Healthcare
CEO
Gareth Sheridan
Headquarters
121 South Orange Avenue, Orlando, FL, US
Description

Nutriband Inc. is a pharmaceutical company dedicated to advancing a diverse pipeline of transdermal drug products. Foremost among its developmental initiatives is an abuse-deterrent fentanyl transdermal system.

This innovative patch aims to provide both healthcare providers and patients with an extended-release fentanyl solution for the effective management of chronic pain. Beyond its core transdermal portfolio, Nutriband Inc. also holds a licensing agreement with Rambam Med-Tech Ltd. for the development of RAMBAM Closed System Transfer Devices.

Established in 2016, the company maintains its corporate headquarters in Orlando, Florida.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Nutriband Inc. from FRC's valuation model, read against the market price. NTRBW last traded at $0.55; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Nutriband Inc.. Starting points for Nutriband Inc.: EPS -$0.57, beta 1.97 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Nutriband Inc.. Nutriband Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Nutriband Inc.. Trailing twelve-month EPS for Nutriband Inc. stands at -$0.57. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Earnings Estimate

EPSCurrent QtrJul 2022Next QtrOct 2022Current YearFY Jan 2027Next YearFY Jan 2028
Avg. estimate-$0.04-$0.04$1.57$3.66
Low estimate-$0.04-$0.04$1.57$3.66
High estimate-$0.04-$0.04$1.57$3.66
No. of analysts1111
Year-ago EPS——-$2.581—
Growth————

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrJul 2022Next QtrOct 2022Current YearFY Jan 2027Next YearFY Jan 2028
Avg. estimate$465000.00$433500.00$95.41M$180.41M
Low estimate$465000.00$433500.00$95.41M$180.41M
High estimate$465000.00$433500.00$95.41M$180.41M
No. of analysts1111
Year-ago revenue——$2.04M—
Growth——+4584.7%—

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Nutriband Inc.. Nutriband Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold NTRBW19 companies · 8 funds
Compare NTRBW with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • BOLDBoundless Bio, Inc.Biotechnology$57M
  • CVKDCadrenal Therapeutics, Inc. Common StockBiotechnology$5M
  • IBIOiBio, Inc.Biotechnology$50M
  • IGCIGC Pharma, Inc.Biotechnology$20M
  • INTSIntensity Therapeutics, Inc.Biotechnology$8M
  • NRSNNeuroSense Therapeutics Ltd.Biotechnology$3M
  • PLURPluri Inc.Biotechnology$11M

More Biotechnology companies

  • BTC.AXBTC Health LimitedASX
  • BVAXFBioVaxys Technology Corp.OTC$3M
  • BVNKFBavarian Nordic A/SOTC$2.4B
  • BVNRYBavarian Nordic A/SOTC$2.4B
  • BXPHFBotanix Pharmaceuticals LimitedOTC$89M
  • BXRXQBaudax Bio, Inc.OTC$436
  • BYSIBeyondSpring Inc.NASDAQ$24M
  • ARUXFAcrux LimitedOTC$2M
  • ARVNArvinas, Inc.NASDAQ$443M
  • ARWRArrowhead Pharmaceuticals, Inc.NASDAQ$6.2B
  • ASBPAspire Biopharma Holdings, Inc.NASDAQ$929,898
  • ASBPWAspire Biopharma Holdings, Inc.NASDAQ$134,572

ETFs holding Nutriband Inc.

% of the fund

  • VTIVanguard Total Stock Market ETF$689.2B in assets
  • VXFVanguard Extended Market ETF$30.2B in assets
  • VUN.TOVanguard U.S. Total Market Index ETF$20.1B in assets
  • VEQT.TOVanguard All-Equity ETF Portfolio$17.6B in assets
  • VGRO.TOVanguard Growth ETF Portfolio$10.9B in assets
  • VBAL.TOVanguard Balanced ETF Portfolio$6.0B in assets
  • VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)$1.4B in assets
  • VCNS.TOVanguard Conservative ETF Portfolio$977M in assets

Largest holders first, then the funds most concentrated in NTRBW.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Nutriband Inc., and how their positions are changing. At a $76.8M market value, institutional positions materially move Nutriband Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Nutriband Inc. executives and directors. Shares of Nutriband Inc. have traded between $0.25 and $2.99 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Nutriband Inc.. Coverage tracks Nutriband Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Nutriband Inc.

NTRBW Analysis
Weak
Past1
Growth1
Health5
Profit1
Value1

News

Latest Market News